ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Hyperscale Data Inc

Hyperscale Data Inc (GPUS-D)

24.15
0.0499
(0.207054%)
Closed 23 January 8:00AM
24.15
0.00
(0.00%)
After Hours: 8:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
24.15
Bid
-
Offer
-
Volume
3,391
22.30 Day's Range 24.15
0.00 52 Week Range 0.00
Previous Close
24.10
Open
23.21
Last Trade
100
@
24.1499
Last Trade Time
Average Volume (3m)
-
Financial Volume
US$ 81,174
VWAP
23.94

GPUS-D Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

GPUS-D - Frequently Asked Questions (FAQ)

What is the current Hyperscale Data share price?
The current share price of Hyperscale Data is US$ 24.15
What is the 1 year trading range for Hyperscale Data share price?
Hyperscale Data has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FOXOFOXO Technologies Inc
US$ 0.2753
(22.36%)
104.79M
MINFT Limited
US$ 3.38
(21.58%)
65.37k
NFLUT Rex 2X Long NFLX Daily Target ETF
US$ 41.65
(17.79%)
281.19k
PAPLPineapple Financial Inc
US$ 0.528
(16.22%)
6.17M
LCTXLineage Cell Therapeutics Inc
US$ 0.6788
(15.36%)
2.93M
HUSAHouston American Energy Corp
US$ 1.8222
(-23.11%)
4.55M
PTNPalatin Technologies Inc New
US$ 0.94
(-14.55%)
496.55k
BURUNuburu Inc
US$ 0.3743
(-13.95%)
1.72M
TPETTrio Petroleum Corp
US$ 2.32
(-12.78%)
2.48M
ROLRHigh Roller Technologies Inc
US$ 4.40
(-12.18%)
77.84k
FOXOFOXO Technologies Inc
US$ 0.2753
(22.36%)
104.79M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 35.15
(4.33%)
52.24M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 16.90
(-4.25%)
46.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.21
(4.00%)
44.89M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.69
(-1.56%)
44.66M

Discussion

View Full Feed
boarddork boarddork 4 minutes ago
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 5 minutes ago
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 5 minutes ago
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 6 minutes ago
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 7 minutes ago
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 7 minutes ago
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 10 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 10 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 11 minutes ago
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 12 minutes ago
Whats 305
RNVA
theorysuit theorysuit 13 minutes ago
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 13 minutes ago
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 minutes ago
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 14 minutes ago
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 14 minutes ago
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 15 minutes ago
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 16 minutes ago
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 16 minutes ago
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 17 minutes ago
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

Your Recent History

Delayed Upgrade Clock